
Valneva inks $59m JE vaccine supply contract
Under the agreement, Valneva will supply its FDA-approved preventive vaccine for Japanese encephalitis (JE) from 2019 to 2020. There is a minimum...

Driver of GVHD after blood stem cell transplantation identified
The results of the team headed by Sonia Tugues from ETH Zürich solve a paradox in the field of allogenic blood stem cell...

XyloCor Therapeutics bags US$17m in Series A financing
The Amsterdam-based company said it will primarily use the proceeds to advance its lead product XC001, licenced from Weill Cornell Medicine, to...

Sugar replacement slows cancer growth
Feeding mannose either alone or alongside chemotherapy through a feeding tube three times a week and continuously via their drinking water was...


BioFIT: innovation and investors
Around 1.500 people came to Lille to participate in the event. BioFIT is hitting a nerve, says Etienne Varvaecke. The general manager of Eurosanté,...

Adrenomed bags €24m in growth financing
The company said it will use the proceeds to advance clinical testing of adrecizumab, the companies first-in-class antibody targeting endothelial...

UK launches new payment model for antimicrobials
A 5-year plan to tackle antimicrobial resistance (AMR) published by the UK government has ambitious goals. Using electronic prescription, it aims at...